IL1B and type 2 diabetes mellitus: However, ASCs from T2D patients significantly expressed higher levels of the diabetogenic mediator, IL-1β gene, and protein, than ASCs from nondiabetic donors (ndASCs) (Abu-Shahba et al. 2021).